ACLARA BIOSCIENCES INC·4

Dec 14, 6:38 PM ET

TANG OSCAR 4

4 · ACLARA BIOSCIENCES INC · Filed Dec 14, 2004

Insider Transaction Report

Form 4
Period: 2004-12-10
Transactions
  • Disposition to Issuer

    Common Stock

    2004-12-1050,0000 total
  • Disposition to Issuer

    Common Stock

    2004-12-1059,2060 total(indirect: By Partnership)
  • Disposition to Issuer

    Common Stock

    2004-12-10335,8000 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2004-12-10162,5000 total(indirect: In Managed Accounts)
  • Disposition to Issuer

    Common Stock

    2004-12-1015,7940 total(indirect: By Partnership)
Footnotes (6)
  • [F1]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc. in exchange for 276,250 shares of Virologic, Inc. common stock. Reporting Person also an equal number of contingent value rights, which may be settled in the form of additional shares of Virologic, Inc. common stock pursuant to the terms of the Agreement of Merger("Contingent Value Rights").
  • [F2]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 570,860 shares of Virologic, Inc. common stock. Reporting person also received 570,860 Contingent Value Rights.
  • [F3]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 100,650 shares of Virologic, Inc. common stock. Reporting person also received 100,650 Contingent Value Rights.
  • [F4]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 26,850 shares of Virologic, Inc. common stock. Reporting person also received 26,850 Contingent Value Rights.
  • [F5]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 85,000 shares of Virologic, Inc. common stock. Reporting person also received 85,000 Contingent Value Rights.
  • [F6]Reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    rrd61360.xmlPrimary

    FORM 4